These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31239235)

  • 1. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
    Williams KV; Becker DJ; Orchard TJ; Costacou T
    J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.
    ; Ahmad I; ; Ali M; Hussain M;
    J Pak Med Assoc; 2024 Aug; 74(8):1441-1448. PubMed ID: 39160710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
    Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
    J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
    Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
    Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
    Lloyd CE; Becker D; Ellis D; Orchard TJ
    Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
    Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
    Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
    Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later.
    Salardi S; Porta M; Maltoni G; Cerutti F; Rovere S; Iafusco D; Tumini S; Cauvin V; Zucchini S; Cadario F; dʾAnnunzio G; Toni S; Salvatoni A; Zedda MA; Schiaffini R;
    J Diabetes Complications; 2016; 30(1):55-60. PubMed ID: 26598223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.